Outset Medical (OM) Gains from Investment Securities (2025)
Outset Medical's (OM) quarterly Gains from Investment Securities came in at $4.4 million in Q1 2025.
Outset Medical (OM) Gains from Investment Securities (2025) Analysis & Trends
Outset Medical (OM) has 1 years of Gains from Investment Securities data on file, last reported at $4.4 million in Q1 2025.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $4.4 million in Q1 2025; TTM through Dec 2025 was $4.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.4 million, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2025 stood at $4.4 million.
- Over the last five years, Gains from Investment Securities for OM reached as high as $4.4 million in Q1 2025 and fell as low as $4.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Outset Medical | 79,371.36 | -286.56 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.37 Mn |
| Mar 31, 2025 | 4.37 Mn |